Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95,300 | 59,800 | 61,700 | 21,300 | 112,000 |
| Depreciation Amortization | 215,400 | 161,700 | 107,000 | 53,200 | 213,500 |
| Income taxes - deferred | -1,100 | -1,700 | -4,300 | -1,600 | -20,200 |
| Accounts receivable | 4,200 | 40,600 | 29,600 | 50,100 | -22,000 |
| Accounts payable and accrued liabilities | 36,500 | -45,700 | 26,300 | -42,300 | -23,500 |
| Other Working Capital | 44,100 | -45,000 | 46,300 | 4,400 | -73,700 |
| Other Operating Activity | 16,400 | 50,300 | -29,800 | 3,300 | 84,800 |
| Operating Cash Flow | $410,800 | $220,000 | $236,800 | $88,400 | $270,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -108,000 | -85,900 | -60,500 | -27,500 | -128,100 |
| Net Acquisitions | -2,500 | -2,500 | -1,500 | N/A | -209,900 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -500 |
| Investing Cash Flow | $-110,500 | $-88,400 | $-62,000 | $-27,500 | $-338,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 390,200 | 390,200 | N/A | N/A | 218,900 |
| Debt Repayment | -402,700 | -397,900 | -11,900 | -6,300 | -227,700 |
| Common Stock Issued | 100 | 100 | 100 | N/A | 500 |
| Common Stock Repurchased | -400 | -400 | -500 | -500 | N/A |
| Dividend Paid | -110,800 | -83,100 | -55,400 | -27,700 | -184,200 |
| Other Financing Activity | -18,800 | -18,400 | -9,600 | -9,600 | -4,900 |
| Financing Cash Flow | $-142,400 | $-109,500 | $-77,300 | $-44,100 | $-197,400 |
| Beginning Cash Position | 170,200 | 170,200 | 170,200 | 170,200 | 435,200 |
| End Cash Position | 328,100 | 192,300 | 267,700 | 187,000 | 170,200 |
| Net Cash Flow | $157,900 | $22,100 | $97,500 | $16,800 | $-265,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 410,800 | 220,000 | 236,800 | 88,400 | 270,900 |
| Capital Expenditure | -108,800 | -86,300 | -60,900 | -27,900 | -131,700 |
| Free Cash Flow | 302,000 | 133,700 | 175,900 | 60,500 | 139,200 |